Search earnings tickers

GILD

2025Q3AMC

Gilead Sciences Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-10-30 · Fiscal end 2025-09-30 · Features as of 2025-10-30

← Earnings history

Street

Consensus EPS2.14

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.4%

IV front—

P/C full—

P/C front—

Features as of2025-10-30

Run-up

Close—

Ret 5d-1.9%

Ret 10d+0.5%

Ret 20d+7.1%

Ret 30d+4.2%

Print

Actual EPS

2.47Beat

Estimated EPS2.14

Actual revenue

7.8B

Surprise %+15.4%

Beat / missBeat

Beat streak 44

Beat streak 87

Reaction

1-day stock reaction+3.2%

Implied vs actual

Implied 2.4%Actual 2.0%

Gap reaction-2.0%

Day result+1.1%

Next-day upYes

Realized / IV0.85×

Post tape

Post 5d-0.8%

Post 10d+4.4%

Post volume10.0M

Vol ×10d1.46×

Vol ×20d1.46×

Post range6.8%